The authors identified multiple gene sets, which were specifically enriched in the BCR-ABL+ SC but could also detect genes, which were able to differentiate BCR-ABL− HSC in CML patients from normal HSCs in control samples. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.